Kono S, Miyajima H, Sugimoto M, Suzuki Y, Takahashi Y, Hishida A
First Department of Medicine, Hamamatsu University School of Medicine.
Intern Med. 2001 Sep;40(9):968-71. doi: 10.2169/internalmedicine.40.968.
Glutamic acid decarboxylase (GAD) is the main target of humoral autoimmunity in patients with insulin-dependent diabetes mellitus (IDDM) and stiff-person syndrome. We reviewed the case of a 46-year-old woman who had cerebellar ataxia before getting stiff-person syndrome and IDDM with high anti-GAD autoantibody titers. This was a rare case in which there were both the clinical symptoms of stiff-person syndrome and cerebellar ataxia. In western blot analysis her serum reacted with 65-kDa proteins from rat cerebellum, cerebral cortex, and spinal cord. Autoantibodies to GAD may cause functional impairment of gamma-aminobutyric acid (GABA) neurons in the spinal cord as well as in the cerebellum.
谷氨酸脱羧酶(GAD)是胰岛素依赖型糖尿病(IDDM)和僵人综合征患者体液自身免疫的主要靶点。我们回顾了一例46岁女性病例,该患者在出现僵人综合征和IDDM之前患有小脑共济失调,且抗GAD自身抗体滴度很高。这是一例罕见的同时出现僵人综合征临床症状和小脑共济失调的病例。在蛋白质印迹分析中,她的血清与来自大鼠小脑、大脑皮层和脊髓的65 kDa蛋白质发生反应。抗GAD自身抗体可能会导致脊髓以及小脑中γ-氨基丁酸(GABA)神经元的功能受损。